Here, we report that the triagonist IUB447 did not enhance cAMP accumulation in pancreatic islets and blocking of the adenylate cyclase had a minimal impact on triagonist-induced insulin secretion
Adequate collagen production is crucial for maintaining healthy hair, skin, and nails
A new survey reports that the obesity rate among adults in the United States is declining as the use of GLP-1 weight loss drugs rises rapidly
8 Even more specifically, a double-blind, placebo-controlled, parallel-group study, conducted in Egypt assessed the effectiveness of L-carnitine on the occurrence of ovulation and pregnancy in women seeking healthy fertility.* 9 Women were randomly assigned to one of two groups
Janowski, M., Lukomska, B
Who It's For (Based on Trial Inclusion Criteria) BMI 30 (obesity) OR BMI 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, high cholesterol, sleep apnea) Adults ages 1875 (some trials include narrower age ranges) People who have tried lifestyle interventions (diet and exercise) without sufficient weight loss Those with type 2 diabetes seeking both glucose control and weight loss People with obesity-related conditions that would improve with major weight reduction Who Should Avoid Retatrutide Based on trial exclusion criteria and the drug's mechanism, retatrutide is likely not appropriate for: Pregnancy or breastfeeding: Not studied in these populations
